Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?

Dig Liver Dis. 2020 Feb;52(2):239-240. doi: 10.1016/j.dld.2019.10.016. Epub 2019 Nov 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Liver Transplantation*
  • Prevalence
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Symporters*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose